DNA Traits · Reproductive biology
Natural menopause timing, UIMC1 marker
The age at which periods stop naturally.

What the research found
In the cited research, the T allele at rs365132 was associated with later age at natural menopause in studied women.
- GG
- Earlier
- GT
- Middle
- TT
- Later
What the study found
In the study, each copy went with age at natural menopause about 0.32 years higher on average.
- Evidence
- Genome-wide association with independent replication
- Who was studied
- Women of European descent
The research behind this card was done only in women, so it is part of a report requested as female.
How common each genotype is
| Region | GGEarlier | GTMiddle | TTLater |
|---|---|---|---|
| All regions2,504 people | 20% | 42% | 38% |
| Africa661 people | 1% | 21% | 78% |
| The Americas347 people | 33% | 46% | 21% |
| East Asia504 people | 25% | 51% | 23% |
| Europe503 people | 26% | 50% | 24% |
| South Asia489 people | 26% | 49% | 26% |
Among the 2,504 people of the 1000 Genomes Project, in five world regions. These percentages describe groups of people, never anyone’s chance of having a trait.
Through time
How often the studied letter was read in ancient people, era by era, in the region chosen.
| Before farmingbefore 6500 BC | 52%31 of 60 copies read |
|---|---|
| First farmers6500 to 3000 BC | 50%227 of 454 copies read |
| Bronze Age3000 to 1200 BC | 47%162 of 347 copies read |
| Iron Age and Antiquity1200 BC to AD 600 | 45%357 of 785 copies read |
| Middle AgesAD 600 to 1500 | 49%469 of 959 copies read |
| Today1000 Genomes | 49%491 of 1,006 copies |
Neanderthal and Denisovan genomes
- Altai Neanderthal
- 2 copies
- Vindija Neanderthal
- Not read
- Chagyrskaya Neanderthal
- Not read
- Denisovan
- 2 copies
Neanderthals and Denisovans carried this letter too: it is the older of the two.
The marker
- Gene or region
- UIMC1 (RAP80)
- Marker
- rs365132
- Location
- Chromosome 5 · GRCh37 176,378,574 · GRCh38 176,951,573
- Letters studied
- G and T, with T as the studied allele
A DNA Traits report reads this marker in your raw DNA file and shows which of the three genotypes is yours, with how common it is. It counts the copies of the studied allele; it does not measure the trait itself.
- Marker
- UIMC1 (RAP80) · rs365132
- Location
- Chromosome 5 · GRCh37 176,378,574 · GRCh38 176,951,573
- Studied allele
- T
- Published statistic
- Replication beta +0.319 years per T allele (SE 0.046), P 4.26e-12, T frequency 0.494; discovery +0.275 (SE 0.029), P 1.90e-21; combined +0.287 (SE 0.025), P 9.11e-32 (Stolk 2012 Table 1). He 2009 Table 1 joint +0.39 (SE 0.052) per T, P 8.4e-14; Day 2015 Table 1 -0.24 (SE 0.02) per G, P 1.4e-33 (Table 1, rs365132 row (region 5b), Replication line)
- 1000 Genomes Project phase 3, people with 0, 1 and 2 copies
- All regions 508 / 1045 / 951 · Africa 9 / 137 / 515 · The Americas 115 / 158 / 74 · East Asia 127 / 259 / 118 · Europe 131 / 253 / 119 · South Asia 126 / 238 / 125
What it cannot tell you
Studied in women of European descent and concerns natural menopause, not menopause after surgery or treatment. A single marker, one of about 290 linked to the age at natural menopause.
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways (Stolk et al., 2012)More in Reproductive biology
- First period timing association
- Natural menopause timing association
- Fraternal twinning association
- Total testosterone association in men
- SHBG association
- FSH regulation association in men
- DHT research association in older men
- Fraternal twinning, SMAD3 marker
- Natural menopause timing, TDRD3 marker
- Natural menopause timing, TMEM150B marker
- Natural menopause timing, ASH2L marker
- First period timing, 9q31 marker
- First period timing, MKL2 marker
- Voice breaking timing, LIN28B marker
- Voice breaking timing, MKL2 marker
- Voice breaking timing, JHY marker
- Voice breaking timing, 9q31 marker
See your own two letters.
Upload the raw DNA file you already have. Your report reads this marker and every other card studied for you, each with its evidence and its limits.